SEELQ Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: October 23, 2024
Report Source: 2024 2nd Quarter Report
Seelos Therapeutics Inc. Stock Analysis SEELQ
United States Health Care Nano Cap Report: Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The company is headquartered in New York City, New York and currently employs 8 full-time employees. The company has filed a voluntary petition under chapter 11 of Title 11 of the United States Code in the United States Bankruptcy Court for the Southern District of New York.
Read More Seelos Therapeutics Inc (SEELQ) Chart
Key Statistics of Seelos Therapeutics Inc (SEELQ)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.00Volume
100.00P/E Ratio (TTM)
-52 Week Range
Market Cap
112.40Avg. Volume
100.00Dividend Yield
-Financial Metrics & Statements of Seelos Therapeutics Inc (SEELQ)
FAQ's for Seelos Therapeutics Inc (SEELQ)
- According to Musaffa’s Shariah screening methodology, Seelos Therapeutics Inc (SEELQ) is currently classified as NOT HALAL as of October 2024. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.